Products for Research Use Only

Risdiplam-hydroxylate-d6

CAT: 0804-HY-109101AS2Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-109101AS2Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Risdiplam-hydroxylate-d6 is a Risdiplam-hydroxylate tritium substitute. Risdiplam (RG7916) is an orally administered, centrally and peripherally distributed SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels[1].
UNSPSC
12352005
Target
DNA/RNA Synthesis; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Cell Cycle/DNA Damage; Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Solubility
10 mM in DMSO
Smiles
O=C1C=C(C2=NN3C=C(C([2H])([2H])[2H])N=C3C(C([2H])([2H])[2H])=C2)N=C4C=CC(N5CCN(C6(CC6)C5)O)=CN14
Molecular Formula
C22H17D6N7O2
Molecular Weight
423.50
References & Citations
[1]Ratni H, et al. Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA) . J Med Chem. 2018 Aug 9;61 (15) :6501-6517.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported